Navigation Links
Intrepid Investment Bankers LLC Advises A-Med Health Care in the Sale of its Specialty Pharmacy Assets to Modern HC Pharmacy, Inc., a portfolio company of Altamont Capital Partners
Date:7/27/2012

LOS ANGELES, July 27, 2012 /PRNewswire/ -- Intrepid Investment Bankers LLC ("Intrepid"), a leading middle market investment banking firm, today announced the sale of the specialty pharmacy assets of A-Med Health Care ("A-Med") to Modern HC Pharmacy, Inc. ("Modern"), a newly formed portfolio company of Altamont Capital Partners ("ACP").  The transaction closed on July 24, 2012. Intrepid acted as the exclusive M&A advisor to A-Med in connection with the specialty pharmacy asset sale. 

(Logo:  http://photos.prnewswire.com/prnh/20120315/LA70428LOGO)

Founded in 1982 and headquartered in Huntington Beach, California, A-Med is a leading provider of medical supplies and specialty pharmaceuticals to patients throughout the United States.  A-Med's specialty pharmacy operation principally services Medicare, Medicaid / Medi-Cal and managed care patients across several disease states including, cystic fibrosis, HIV / AIDS and transplant patients.

Modern is a newly formed entity created to combine the specialty pharmacy assets of A-Med with the specialty pharmacy assets of Modern HEALTHcare, Inc., which provides long-term care medication programs for skilled nursing and assisted living communities and specialized pharmacy services to individuals challenged with a broad range of chronic health conditions.  ACP is a private equity sponsor based in the San Francisco Bay area with $500 million in capital, focused on investing in change-intensive middle market businesses across several industries, including healthcare.

Ed Bagdasarian, Managing Director of Intrepid, commented, "We were pleased to have the opportunity to work closely with the owners and management team of A-Med through the sale process.  After starting the specialty pharmacy in 2003 and growing it considerably, the owners of A-Med decided to pursue  its divestiture so that A-Med could focus on building its core medical supplies business.  The transaction represented the culmination of a complex three-party combination that best achieves the objectives of A-Med's owners and allows management to focus on driving the growth of its medical supplies unit.  This transaction continues our team's long track record of completing successful transactions in the healthcare sector."

"We are very appreciative of the work done by the team at Intrepid.  This was a highly complex transaction and Intrepid demonstrated a thorough understanding of our business needs and the unique aspects of a specialty pharmacy in today's changing healthcare environment," said Larry Thacker, President and CEO of A-Med.  "We are pleased to be selling the specialty pharmacy assets to Modern and ACP and wish them the best of luck in achieving their objectives and goals."

The Intrepid team included Ed Bagdasarian, Gary Rabishaw, Jeremiah Mann, Shahriar Attaie and Chris Neils.

About Intrepid Investment Bankers LLC 

Intrepid Investment Bankers LLC, based in Los Angeles, California, is a mergers and acquisitions and corporate finance advisory firm focused on the middle-market. Intrepid was founded in 2010 by the former principals of Barrington Associates, a firm that grew to become a leading national middle market M&A advisor before its acquisition by Wells Fargo in 2006. Intrepid's services include M&A advisory, equity and debt capital raising and providing strategic advice in complex securities transactions. The firm focuses on the middle market corporate finance needs of entrepreneur and family-owned businesses, private equity sponsors and major corporations. Collectively, the senior team at Intrepid brings over 150 years of mergers and acquisitions advisory experience and has advised on over 250 transactions spanning a broad range of industries, including consumer products and services, industrial manufacturing, healthcare products and services, building products, business services and retail. www.intrepidib.com Member FINRA/SIPC. 


'/>"/>
SOURCE Intrepid Investment Bankers LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
2. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
3. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
4. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
5. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
6. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
7. Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai
8. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
9. Cardiosolutions, Inc. Gathers Major Investment from Sorin Group
10. Apex BioStrategists Advises On Flow Cytometry Sale To Coulter
11. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... According to a new market report ... U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 ... was valued at US$ 5.89 Bn in 2014 and is ... to 2023 to reach US$ 7.99 Bn in 2023. ... needle free drug delivery devices and the market is estimated ...
(Date:5/26/2016)... A key trend that will ... of new treatments. Cardax, a development stage life sciences ... therapy is expected to fulfil large unmet medical needs ... studies to develop new treatments for osteoarthritis. One such ... in osteoarthritis are being investigated, and early trials of ...
(Date:5/26/2016)... May 26, 2016 TARE ... Both Cost Savings and Overall Decreased Use ... BTG), an international specialist healthcare company, has today ... 21st Annual Meeting of ISPOR (International Society for ... hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres is ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook ... Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the ... is their favorite way to cook a hot dog, far outpacing other cooking methods ...
(Date:5/26/2016)... Hampshire (PRWEB) , ... May 26, 2016 , ... ... care products, has been honored with a 2016 When Work Works Award for its ... award, part of the national When Work Works project administered by the Families and ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... thousands of defective respirators, according to court documents and SEC filings. A ... and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare ... suppliers for its inaugural Member Conference at the Paris Hotel in Las Vegas, ... operational health of America’s healthcare providers. , The conference was highlighted by the ...
Breaking Medicine News(10 mins):